Autophagy and mitochondrial function pathways in muscle cells

Autophagy and mitochondrial function pathways in muscle cells represent a complex network of processes essential for maintaining muscle mass, strength, and metabolic health (Sandri, 2013, Nature Reviews Molecular Cell Biology). Autophagy serves as the primary cellular recycling mechanism, degrading damaged proteins and organelles, while mitochondrial pathways govern energy production and biogenesis, primarily regulated by the PGC-1alpha coactivator (Hood et al., 2019, Frontiers in Physiology). The intersection of these pathways, known as mitophagy, is essential for removing dysfunctional mitochondria that would otherwise accumulate and cause oxidative damage in post-mitotic muscle tissue (Sebastián et al., 2016, Nature Communications). Dysregulation of these processes is a primary driver of age-related muscle loss (sarcopenia), cancer-associated cachexia, and metabolic disorders like Type 2 diabetes (Grumati et al., 2010, Nature Medicine). Therapeutic targeting of these pathways often involves the use of AMPK activators like Metformin or specific mitophagy enhancers such as Urolithin A, which has demonstrated the ability in clinical trials to improve muscle endurance and mitochondrial health markers in humans (Andreux et al., 2019, Nature Metabolism). Because this 'target' encompasses an entire physiological system rather than a single molecule, drug development focuses on specific regulatory nodes like PINK1, Parkin, or ULK1 to restore the balance between organelle synthesis and degradation.

Other names

Muscle autophagy-mitochondrial axisMitophagy in skeletal muscleMuscle proteostasis and bioenergetics pathwaysMitochondrial quality control in muscle

Modulation of cellular energy sensors such as AMPK and mTORC1 to stimulate the clearance of damaged organelles (mitophagy) and promote the synthesis of new, functional mitochondria via PGC-1alpha signaling.